Evidence-Based Comparison of Commercial Interferon-γ Release Assays for Detecting Active TB
- 1 April 2010
- journal article
- research article
- Published by Elsevier BV in Chest
- Vol. 137 (4), 952-968
- https://doi.org/10.1378/chest.09-2350
Abstract
No abstract availableThis publication has 117 references indexed in Scilit:
- Diagnostic Usefulness of a T-cell-based Assay for Extrapulmonary Tuberculosis in Immunocompromised PatientsAmerican Journal Of Medicine, 2009
- Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis countryAIDS, 2008
- Prevalence of latent tuberculosis infection in German radiologistsJournal of Hospital Infection, 2008
- Reproducibility of QuantiFERON-TB Gold In-Tube AssayClinical and Vaccine Immunology, 2008
- Use of Whole-Blood Samples in In-House Bulk and Single-Cell Antigen-Specific Gamma Interferon Assays for Surveillance of Mycobacterium tuberculosis InfectionsClinical and Vaccine Immunology, 2008
- Comparison of Two Commercially Available Gamma Interferon Blood Tests for Immunodiagnosis of TuberculosisClinical and Vaccine Immunology, 2008
- Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot studyClinical and Experimental Immunology, 2007
- Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced diseaseClinical and Experimental Immunology, 2007
- Comparison of an ESAT-6/CFP-10 Peptide-Based Enzyme-Linked Immunospot Assay to a Tuberculin Skin Test for Screening of a Population at Moderate Risk of Contracting TuberculosisClinical and Vaccine Immunology, 2007
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007